Enhancing gene therapy with Circio
Drug Target Review
MAY 22, 2024
In parallel, we are exploring the technical performance of circVec in other viral vectors, as well as non-viral approaches which we expect will surpass virus-based vector-format as the state-of-the-art solutions for gene therapy in the future. We are now running follow-up experiments to track the advantage long-term.
Let's personalize your content